Australian & New Zealand Mental Health Association AddictionZ 2025

Australian & New Zealand Mental Health Association AddictionZ 2025

Include: 2 videos + 1 pdf, size: 39.23 GB
Target Audience: psychiatry physicians
Information:

A cross-disciplinary program focused on prevention, treatment, and recovery across alcohol, tobacco, and other drugs (ATOD). Sessions blend evidence, policy, and lived experience to turn research into practical services that work in real communities.

What You Will Learn

• Screening and brief intervention (SBIRT) tailored to primary care, ED, and community settings

• Evidence-based care for alcohol, opioids, stimulants, cannabis, and polysubstance use

• Harm reduction and overdose prevention, including post-overdose engagement pathways

• Managing co-occurring mental and physical health conditions, trauma, and pain

• Youth, perinatal, and culturally safe approaches (First Nations and Māori/Pasifika contexts)

• Service design: integrated models, digital health, workforce wellbeing, and quality improvement

Event Details

• Format: Keynotes, case studies, concurrent sessions, workshops, and panels

• Structure: Prevention & early intervention → Treatment & harm reduction → Recovery & lived experience → Systems & policy

• Takeaways: Toolkits, protocols, and metrics you can deploy immediately

Who Should Attend
Clinicians (medicine, nursing, psychology, social work), peer workers, public health leaders, program managers, NGOs, government and commissioning bodies, researchers, educators, and community advocates.

Why Attend

• Convert guidelines and policy into clear, context-fit care pathways

• Learn what works from real programs—outcomes, pitfalls, and scalability

• Build cross-sector partnerships that improve access, equity, and continuity of care

 

Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

• Alcohol, opioids, stimulants, cannabis, vaping and emerging substances

• Harm reduction: naloxone, needle/syringe, supervised consumption, safer-use education

• Co-occurring conditions: depression, anxiety, PTSD, psychosis, infectious diseases, chronic pain

• Youth & perinatal services; family-inclusive and culturally safe care

• Justice, homelessness, rural/remote delivery, and disaster-affected communities

• Digital tools & data: telehealth, apps, dashboards, privacy and ethics

• Workforce: recruitment/retention, supervision, burnout prevention, peer leadership

• Evaluation & commissioning: outcomes, ROI beyond dollars (retention, safety, community vitality)